Hem/Onc Roundup: Similar Risk Factors for Racial Disparity in Cancer and COVID-19, and More

Risk Factors for Racial Disparities Are Similar for Cancer and COVID-19

Factors that lead to racial disparities in cancer, including health comorbidities, education level, and more, are similar for COVID-19, according to a study. Despite the significant differences between the two diseases, factors that are associated with racial disparities in both diseases include socioeconomic disadvantages, level of education, lifestyle, health comorbidities, and limited access to medical care, the researchers found.

Risk Factors for Racial Disparities Are Similar for Cancer and COVID-19

Metabolic Health is a Risk Factor for Pancreatic Cancer, Regardless of Obesity

Metabolic health may be a risk factor for the development of pancreatic cancer, independent of obesity, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. Obesity is a known risk factor for pancreatic cancer, but what is less clear is the effect of metabolism on cancer development.

Metabolic Health is a Risk Factor for Pancreatic Cancer, Regardless of Obesity

Are Oral Anticoagulants Effective Against VTE in Patients with Multiple Myeloma?

Individuals with multiple myeloma (MM) are at increased risk for developing venous thromboembolism (VTE), or blood clots in the veins. According to data presented at the 2020 ASH Annual Meeting & Exposition, the use of direct oral anticoagulants effectively prevented VTE in patients with MM receiving immunomodulatory drugs at similar rates to other anticoagulation regimens.

Are Oral Anticoagulants Effective Against VTE in Patients with Multiple Myeloma?

Triple Chemotherapy Combination that Effectively Treats Metastatic Colorectal Cancer

Research shows that a triple drug combination of irinotecan, cetuximab, and vemurafenib keeps patients with metastatic colorectal cancer disease free for an appreciably longer period of time compared with patients treated with irinotecan and cetuximab. The findings were published in Journal of Clinical Oncology (JCO) and will be accompanied by an editorial in JCO in January 2021.

Triple Chemotherapy Combination that Effectively Treats Metastatic Colorectal Cancer